1. Home
  2. RLMD vs LOCL Comparison

RLMD vs LOCL Comparison

Compare RLMD & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • LOCL
  • Stock Information
  • Founded
  • RLMD 2004
  • LOCL 2021
  • Country
  • RLMD United States
  • LOCL United States
  • Employees
  • RLMD N/A
  • LOCL N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • LOCL Farming/Seeds/Milling
  • Sector
  • RLMD Health Care
  • LOCL Consumer Staples
  • Exchange
  • RLMD Nasdaq
  • LOCL Nasdaq
  • Market Cap
  • RLMD 22.0M
  • LOCL 22.3M
  • IPO Year
  • RLMD N/A
  • LOCL N/A
  • Fundamental
  • Price
  • RLMD $0.61
  • LOCL $2.56
  • Analyst Decision
  • RLMD Buy
  • LOCL
  • Analyst Count
  • RLMD 3
  • LOCL 0
  • Target Price
  • RLMD $5.00
  • LOCL N/A
  • AVG Volume (30 Days)
  • RLMD 338.9K
  • LOCL 20.1K
  • Earning Date
  • RLMD 08-06-2025
  • LOCL 08-12-2025
  • Dividend Yield
  • RLMD N/A
  • LOCL N/A
  • EPS Growth
  • RLMD N/A
  • LOCL N/A
  • EPS
  • RLMD N/A
  • LOCL N/A
  • Revenue
  • RLMD N/A
  • LOCL $41,360,000.00
  • Revenue This Year
  • RLMD N/A
  • LOCL $62.88
  • Revenue Next Year
  • RLMD N/A
  • LOCL $66.75
  • P/E Ratio
  • RLMD N/A
  • LOCL N/A
  • Revenue Growth
  • RLMD N/A
  • LOCL 41.44
  • 52 Week Low
  • RLMD $0.24
  • LOCL $1.18
  • 52 Week High
  • RLMD $4.47
  • LOCL $5.75
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 47.74
  • LOCL 54.27
  • Support Level
  • RLMD $0.60
  • LOCL $2.86
  • Resistance Level
  • RLMD $0.69
  • LOCL $3.14
  • Average True Range (ATR)
  • RLMD 0.07
  • LOCL 0.23
  • MACD
  • RLMD -0.01
  • LOCL 0.07
  • Stochastic Oscillator
  • RLMD 41.86
  • LOCL 47.12

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About LOCL Local Bounti Corporation

Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.

Share on Social Networks: